130 related articles for article (PubMed ID: 35477328)
1. Metastatic Small Bowel Adenocarcinoma Mimicking a Primary Ovarian Mucinous Tumour - Clinical, Radiologic, Pathologic and Molecular Correlation.
Yang H; Yuan R; Alex D; Hughesman C; Liu S; Lee U; Zhou C; Wang G
Int J Surg Pathol; 2023 Feb; 31(1):110-118. PubMed ID: 35477328
[TBL] [Abstract][Full Text] [Related]
2. Role of KRAS and BRAF gene mutations in mucinous ovarian carcinoma.
Gemignani ML; Schlaerth AC; Bogomolniy F; Barakat RR; Lin O; Soslow R; Venkatraman E; Boyd J
Gynecol Oncol; 2003 Aug; 90(2):378-81. PubMed ID: 12893203
[TBL] [Abstract][Full Text] [Related]
3. Mucinous borderline ovarian tumors with BRAF
Ohnishi K; Nakayama K; Ishikawa M; Ishibashi T; Yamashita H; Nakamura K; Minamoto T; Iida K; Razia S; Ishikawa N; Kyo S
Arch Gynecol Obstet; 2020 Aug; 302(2):487-495. PubMed ID: 32556513
[TBL] [Abstract][Full Text] [Related]
4. Molecular characterization of 103 ovarian serous and mucinous tumors.
Vereczkey I; Serester O; Dobos J; Gallai M; Szakács O; Szentirmay Z; Tóth E
Pathol Oncol Res; 2011 Sep; 17(3):551-9. PubMed ID: 21136228
[TBL] [Abstract][Full Text] [Related]
5. Does the primary site really matter? Profiling mucinous ovarian cancers of uncertain primary origin (MO-CUP) to personalise treatment and inform the design of clinical trials.
Meagher NS; Schuster K; Voss A; Budden T; Pang CNI; deFazio A; Ramus SJ; Friedlander ML
Gynecol Oncol; 2018 Sep; 150(3):527-533. PubMed ID: 30054102
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
Chou YY; Jeng YM; Kao HL; Chen T; Mao TL; Lin MC
Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
[TBL] [Abstract][Full Text] [Related]
7. Expression of REG4 in ovarian mucinous tumors.
Huang Q; Chen X; Lu W; Lai M; Lu B
Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
[TBL] [Abstract][Full Text] [Related]
8. High frequency of BRAF mutations in primary mucinous ovarian carcinoma of Taiwanese patients.
Chao WR; Lee YJ; Lee MY; Sheu GT; Han CP
Taiwan J Obstet Gynecol; 2021 Nov; 60(6):1072-1077. PubMed ID: 34794740
[TBL] [Abstract][Full Text] [Related]
9. PPP2R1A mutation is a rare event in ovarian carcinoma across histological subtypes.
Rahman M; Nakayama K; Rahman MT; Nakayama N; Katagiri H; Katagiri A; Ishibashi T; Ishikawa M; Iida K; Otsuki Y; Nakayama S; Miyazaki K
Anticancer Res; 2013 Jan; 33(1):113-8. PubMed ID: 23267135
[TBL] [Abstract][Full Text] [Related]
10. Mucinous carcinoma of thyroid gland. Report of a primary and a metastatic mucinous tumour from ovarian adenocarcinoma with immunohistochemical study and review of literature.
D'Antonio A; Addesso M; De Dominicis G; Boscaino A; Liguori G; Nappi O
Virchows Arch; 2007 Oct; 451(4):847-51. PubMed ID: 17704943
[TBL] [Abstract][Full Text] [Related]
11. Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach.
Talia KL; Parra-Herran C; McCluggage WG
Histopathology; 2022 Jan; 80(2):255-278. PubMed ID: 33963606
[TBL] [Abstract][Full Text] [Related]
12. Pathology of primary and metastatic mucinous ovarian neoplasms.
Leen SL; Singh N
J Clin Pathol; 2012 Jul; 65(7):591-5. PubMed ID: 22075188
[TBL] [Abstract][Full Text] [Related]
13. BRAF-mutated, microsatellite-stable adenocarcinoma of the proximal colon: an aggressive adenocarcinoma with poor survival, mucinous differentiation, and adverse morphologic features.
Pai RK; Jayachandran P; Koong AC; Chang DT; Kwok S; Ma L; Arber DA; Balise RR; Tubbs RR; Shadrach B; Pai RK
Am J Surg Pathol; 2012 May; 36(5):744-52. PubMed ID: 22314188
[TBL] [Abstract][Full Text] [Related]
14. Urachal adenocarcinoma metastatic to the ovary simulating primary mucinous cystadenocarcinoma of the ovary: report of a case.
Young RH
Virchows Arch; 1995; 426(5):529-32. PubMed ID: 7633664
[TBL] [Abstract][Full Text] [Related]
15. RAS Mutation in Mucinous Carcinoma of the Ovary.
Panyavaranant P; Teerapakpinyo C; Pohthipornthawat N; Oranratanaphan S; Shuangshoti S; Triratanachat S
Asian Pac J Cancer Prev; 2019 Apr; 20(4):1127-1132. PubMed ID: 31030485
[TBL] [Abstract][Full Text] [Related]
16. RNF43 is a tumour suppressor gene mutated in mucinous tumours of the ovary.
Ryland GL; Hunter SM; Doyle MA; Rowley SM; Christie M; Allan PE; Bowtell DD; ; Gorringe KL; Campbell IG
J Pathol; 2013 Feb; 229(3):469-76. PubMed ID: 23096461
[TBL] [Abstract][Full Text] [Related]
17. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type.
Rechsteiner M; Zimmermann AK; Wild PJ; Caduff R; von Teichman A; Fink D; Moch H; Noske A
Exp Mol Pathol; 2013 Oct; 95(2):235-41. PubMed ID: 23965232
[TBL] [Abstract][Full Text] [Related]
18. KRAS mutation positive mucinous adenocarcinoma originating in mature ovarian teratoma: case report and review of literature.
Hershkovitz D; Vlodavsky E; Simon E; Ben-Izhak O
Pathol Int; 2013 Dec; 63(12):611-4. PubMed ID: 24422958
[TBL] [Abstract][Full Text] [Related]
19. [Correlation of clinicopathologic features and driver gene mutation in non-small cell lung cancer].
Chen LF; Chen XY; Yu XB
Zhonghua Bing Li Xue Za Zhi; 2016 Apr; 45(4):221-5. PubMed ID: 27033383
[TBL] [Abstract][Full Text] [Related]
20. Metastatic duodenal carcinoma simulating primary mucinous tumor of the ovary.
Sakai Y; Hatano B
Arch Gynecol Obstet; 2005 Jun; 272(1):84-6. PubMed ID: 15300447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
